Lowering of Mean Pulmonary Arterial Pressure is a Prognostic Marker in Pulmonary Hypertension Patients treated with Subcutaneous Treprostinil

被引：0
|
作者：
Sadushi-Kolici, Roela [1 ]
Shafran, Inbal [2 ]
Skoro-Sajer, Nika [1 ]
Gerges, Christian [1 ]
Lang, Irene [1 ]
机构：
[1] Med Univ Vienna, Internal Med 2, Cardiol, Vienna, Austria
[2] Sheba Med Ctr, Ramat Gan, Israel
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA3968
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Lowering of mean pulmonary arterial pressure is a prognostic marker in pulmonary hypertension patients treated with subcutaneous treprostinil
    Sadushi-Kolici, R.
    Shafran, I
    Skoro-Sajer, N.
    Campean, I-A
    Lang, I. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2255 - 2255
  • [2] Lowering of mean pulmonary arterial pressure is a prognostic marker in pulmonary hypertension patients treated with subcutaneous Treprostinil
    Sadushi-Kolici, R.
    Shafran, I.
    Campean, I.
    Skoro-Sajer, N.
    Lang, I.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S286 - S286
  • [3] Lowering of mean pulmonary artery pressure is a prognostic marker in pulmonary hypertension
    Campean, Ioana Alexandra
    Sadushi-Kolici, Roela
    Shafran, Inbal
    Skoro-Sajer, Nika
    Lang, Irene Marthe
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 613 - 614
  • [4] Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
    Barst, R. J.
    Galie, N.
    Naeije, R.
    Simonneau, G.
    Jeffs, R.
    Arneson, C.
    Rubin, L. J.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (06) : 1195 - 1203
  • [5] Subcutaneous treprostinil in pediatric pulmonary arterial hypertension.
    Bajolle, F.
    Levy, M.
    Szezepanski, I.
    Bonnet, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [6] Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations
    Mathier, Michael A.
    McDevitt, Susanne
    Saggar, Rajan
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (11): : 1210 - 1217
  • [7] Experience with subcutaneous treprostinil in children with pulmonary arterial hypertension
    Vernetta, Alba Torrent
    Amigo, Sandra Rovira
    Serrano, Ignacio Iglesias
    Morillo, Maria
    Messa, Ines de Mir
    Gartner, Silvia
    Brotons, Dimpna Albert
    Galdo, Antonio Moreno
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [8] Tolerability and Efficacy of Subcutaneous Treprostinil Therapy in Patients with Pulmonary Arterial Hypertension
    Hatano, Masaru
    Maki, Hisataka
    Minatsuki, Shun
    Komuro, Issei
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S193 - S193
  • [9] Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil
    Ascha, Mona
    Zhou, Xuan
    Rao, Youlan
    Minai, Omar A.
    Tonelli, Adriano R.
    CARDIOVASCULAR THERAPEUTICS, 2017, 35 (05)
  • [10] Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
    Benza, Raymond L.
    Gomberg-Maitland, Mardi
    Naeije, Robert
    Arneson, Carl P.
    Lang, Irene M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (09): : 982 - 989
12345